Ontology highlight
ABSTRACT:
INSTRUMENT(S): impact HD
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: John Burke
LAB HEAD: Dr. John E. Bruke
PROVIDER: PXD053867 | Pride | 2024-08-23
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
11_09_23_Calico6_PT_MSMS.d.rar | Other | |||
12_07_23_HNHDX10_DB_3s-1.d.rar | Other | |||
12_07_23_HNHDX10_PC_30s-1.d.rar | Other | |||
12_07_23_HNHDX10_PC_3s-1.d.rar | Other | |||
12_07_23_HNHDX10_TN_300s-1.d.rar | Other |
Items per page: 1 - 5 of 52 |
Communications chemistry 20240816 1
PTPN2 (protein tyrosine phosphatase non-receptor type 2, or TC-PTP) and PTPN1 are attractive immuno-oncology targets, with the deletion of Ptpn1 and Ptpn2 improving response to immunotherapy in disease models. Targeted protein degradation has emerged as a promising approach to drug challenging targets including phosphatases. We developed potent PTPN2/N1 dual heterobifunctional degraders (Cmpd-1 and Cmpd-2) which facilitate efficient complex assembly with E3 ubiquitin ligase CRL4<sup>CRBN</sup>, ...[more]